Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
35
|
pubmed:dateCreated |
1990-1-19
|
pubmed:abstractText |
We have identified the genetic defect that leads to a deficiency of apoC-II in the proband from the Paris kindred. Analysis of the apoC-IIParis DNA by Southern blot hybridization revealed no major gene rearrangements, but sequencing of polymerase chain reaction-amplified apoC-IIParis DNA revealed an A to G transition that changed the initiation AUG (methionine) codon to GUG (valine). Potential initiation of translation at the closest inframe methionine codon eliminates the entire signal peptide and the first 8 amino-terminal residues of apoC-II which would prevent apoC-II secretion into plasma. In agreement with this, no apoC-II was detected in the patient's plasma by radioimmunoassay or by two-dimensional gel electrophoresis and immunoblotting. Direct sequencing of amplified patient DNA from 12 different polymerase chain reaction samples demonstrated the presence of the A to G substitution in all, indicating that the proband is a homozygote for the defect. We propose that in the apoC-IIParis gene, a mutation in the initiation methionine codon prevents the normal initiation of apolipoprotein synthesis and leads to a deficiency of apoC-II. This initiation methionine mutation represents a new type of molecular defect that can result in Type I hyperlipoproteinemia.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein C-II,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins C,
http://linkedlifedata.com/resource/pubmed/chemical/Codon,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
264
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
20839-42
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2592354-Adult,
pubmed-meshheading:2592354-Apolipoprotein C-II,
pubmed-meshheading:2592354-Apolipoproteins C,
pubmed-meshheading:2592354-Base Sequence,
pubmed-meshheading:2592354-Blotting, Southern,
pubmed-meshheading:2592354-Codon,
pubmed-meshheading:2592354-DNA,
pubmed-meshheading:2592354-Female,
pubmed-meshheading:2592354-Genes,
pubmed-meshheading:2592354-Humans,
pubmed-meshheading:2592354-Molecular Sequence Data,
pubmed-meshheading:2592354-Mutation,
pubmed-meshheading:2592354-Nucleic Acid Hybridization,
pubmed-meshheading:2592354-Polymerase Chain Reaction,
pubmed-meshheading:2592354-RNA, Messenger,
pubmed-meshheading:2592354-Reference Values,
pubmed-meshheading:2592354-Restriction Mapping
|
pubmed:year |
1989
|
pubmed:articleTitle |
An initiation codon mutation in the apoC-II gene (apoC-II Paris) of a patient with a deficiency of apolipoprotein C-II.
|
pubmed:affiliation |
Molecular Disease Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.
|
pubmed:publicationType |
Journal Article,
Case Reports
|